extent of accumulation [NCA / SHAM]

posted by martin  – Austria, 2010-01-13 14:38 (5637 d 02:36 ago) – Posting: # 4595
Views: 21,533

Dear HS!

I have a question regarding estimating the extent of accumulation following repeated study drug administration. I have data from a single dose PK study and I would like to estimate the extent of accumulation in AUCs in the case of repeated study drug administrations.

According to Cawello (2003, page 61-62) "The extent of accumulation can be calculated by the ratio of the dosing interval to the half-life". Accumulation index R = 1/(1-2) where ε = dosing interval divided by half-life.

I suppose the accumulation is based on two assumptionsI have to questions in this context:
  1. In the case that the decline over time can be described by a biexponential decline (two-compartmental model) following an IV bolus with an initial and terminal phase which half-life should be used to estimate the extent of accumulation? I think the terminal half-life is not suitable as the theory of accumulation was developed on assumption of a one-compartmental model. right? I think the effective or non-compartmental half-life calculated as log(2) × MRT would be more suitable. Do you agree?
  2. In the case of only 2 to 4 repeated administration, steady state may not be reached according to Cawello (2003, page 58). In this case I would estimate the accumulation in AUCs based on the principle of superposition. Do you agree?

Best regards

Martin

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
42 visitors (0 registered, 42 guests [including 8 identified bots]).
Forum time: 18:14 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5